Clinical Trials Directory

Trials / Completed

CompletedNCT05809674

Polarization Sensitive Optical Coherence Tomography

Polarization Sensitive Optical Coherence Tomography - Phase II: A Pilot Study

Status
Completed
Phase
Study type
Observational
Enrollment
178 (actual)
Sponsor
Singapore Eye Research Institute · Academic / Other
Sex
All
Age
10 Years – 99 Years
Healthy volunteers
Accepted

Summary

The purpose of the study is to use the polarization sensitive optical coherence tomography (PS-OCT) developed by Singapore Eye Research Institute, to evaluate the potential OCT scleral biomarkers capable of predicting risk of myopia progression.

Conditions

Interventions

TypeNameDescription
DEVICEPolarization sensitive optical coherence tomography (PS-OCT)The PS-OCT is a prototype, also known as an early version of a medical device, specially developed by the Ocular Imaging Research Group, Singapore Eye Research Institute, for prediction of myopia progression. It has not been approved for use in any other country. There is currently no method to identify who is at risk of myopia progression. The PS-OCT device will provide the capabilities of OCT scleral biomarkers, which may have the potential to identify individuals at high risk for myopia.

Timeline

Start date
2022-03-10
Primary completion
2023-03-31
Completion
2023-03-31
First posted
2023-04-12
Last updated
2023-04-12

Locations

1 site across 1 country: Singapore

Source: ClinicalTrials.gov record NCT05809674. Inclusion in this directory is not an endorsement.